These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 32413966)

  • 1. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
    Liu Y; Zhang C
    Cells; 2020 May; 9(5):. PubMed ID: 32413966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-delta (γδ) T cells: friend or foe in cancer development?
    Zhao Y; Niu C; Cui J
    J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
    Li Y; Li G; Zhang J; Wu X; Chen X
    Front Immunol; 2020; 11():619954. PubMed ID: 33664732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?
    Galati D; Zanotta S; Bocchino M; De Filippi R; Pinto A
    Cancer Immunol Immunother; 2021 Jul; 70(7):1797-1809. PubMed ID: 33386466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. γδ T cells and their potential for immunotherapy.
    Wu YL; Ding YP; Tanaka Y; Shen LW; Wei CH; Minato N; Zhang W
    Int J Biol Sci; 2014; 10(2):119-35. PubMed ID: 24520210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
    Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
    Front Immunol; 2018; 9():1990. PubMed ID: 30298063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer immunotherapy with γδ T cells: many paths ahead of us.
    Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
    Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing γδ T cells in anticancer immunotherapy.
    Hannani D; Ma Y; Yamazaki T; Déchanet-Merville J; Kroemer G; Zitvogel L
    Trends Immunol; 2012 May; 33(5):199-206. PubMed ID: 22364810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
    Braza MS; Klein B
    Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors.
    Noguchi A; Kaneko T; Kamigaki T; Fujimoto K; Ozawa M; Saito M; Ariyoshi N; Goto S
    Cytotherapy; 2011 Jan; 13(1):92-7. PubMed ID: 20831354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.
    Paul S; Lal G
    Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of gammadelta T lymphocytes in tumor defense.
    Zocchi MR; Poggi A
    Front Biosci; 2004 Sep; 9():2588-604. PubMed ID: 15358583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γδ T cell responses: How many ligands will it take till we know?
    Vermijlen D; Gatti D; Kouzeli A; Rus T; Eberl M
    Semin Cell Dev Biol; 2018 Dec; 84():75-86. PubMed ID: 29402644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current progress in γδ T-cell biology.
    Hao J; Wu X; Xia S; Li Z; Wen T; Zhao N; Wu Z; Wang P; Zhao L; Yin Z
    Cell Mol Immunol; 2010 Nov; 7(6):409-13. PubMed ID: 21042298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid.
    Fiore F; Castella B; Nuschak B; Bertieri R; Mariani S; Bruno B; Pantaleoni F; Foglietta M; Boccadoro M; Massaia M
    Blood; 2007 Aug; 110(3):921-7. PubMed ID: 17403919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.
    Chan KF; Duarte JDG; Ostrouska S; Behren A
    Front Immunol; 2022; 13():894315. PubMed ID: 35880177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-lymphoma effect of gammadelta T cells.
    Kunzmann V; Wilhelm M
    Leuk Lymphoma; 2005 May; 46(5):671-80. PubMed ID: 16019504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γδ T cells as a potential tool in colon cancer immunotherapy.
    Ramutton T; Buccheri S; Dieli F; Todaro M; Stassi G; Meraviglia S
    Immunotherapy; 2014; 6(9):989-99. PubMed ID: 25341120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
    Miyashita M; Shimizu T; Ashihara E; Ukimura O
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.